Tessari Eben (CIK 1867899) reported 75 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-04-08). Recent activity: Buy KNSA (2,726 shares), Sell KNSA (846 shares), Buy KNSA (365 shares), Buy KNSA (5,975 shares), Sell KNSA (1,756 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-08 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF STRATEGY OFFICER | Buy | 2,726 | $0 |
| 2026-04-08 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF STRATEGY OFFICER | Sell | 846 | $41,403 |
| 2026-04-03 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF STRATEGY OFFICER | Buy | 365 | $8,818 |
| 2026-04-03 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF STRATEGY OFFICER | Buy | 5,975 | $0 |
| 2026-04-03 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF STRATEGY OFFICER | Sell | 1,756 | $84,516 |
| 2025-12-17 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF OPERATING OFFICER | Buy | 6,000 | $52,980 |
| 2025-12-17 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF OPERATING OFFICER | Sell | 12,048 | $500,715 |
| 2025-12-01 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF OPERATING OFFICER | Buy | 200 | $4,578 |
| 2025-12-01 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF OPERATING OFFICER | Sell | 200 | $8,578 |
| 2025-11-19 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF OPERATING OFFICER | Buy | 6,500 | $57,395 |
| 2025-11-19 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF OPERATING OFFICER | Sell | 645 | $25,852 |
| 2025-11-19 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF OPERATING OFFICER | Sell | 11,825 | $488,372 |
| 2025-10-16 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF OPERATING OFFICER | Buy | 6,500 | $57,395 |
| 2025-10-16 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF OPERATING OFFICER | Sell | 11,815 | $444,835 |
| 2025-10-16 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF OPERATING OFFICER | Sell | 553 | $21,008 |
| 2025-10-01 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF OPERATING OFFICER | Buy | 42,000 | $752,640 |
| 2025-10-01 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF OPERATING OFFICER | Sell | 42,000 | $1.6M |
| 2025-09-17 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF OPERATING OFFICER | Buy | 6,500 | $57,395 |
| 2025-09-17 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF OPERATING OFFICER | Sell | 16,044 | $584,804 |
| 2025-09-17 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF OPERATING OFFICER | Sell | 356 | $13,172 |
| 2025-09-08 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF OPERATING OFFICER | Buy | 38,725 | $600,238 |
| 2025-09-08 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF OPERATING OFFICER | Buy | 46,546 | $722,394 |
| 2025-09-08 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF OPERATING OFFICER | Sell | 85,271 | $3.0M |
| 2025-09-08 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF OPERATING OFFICER | Buy | 13,389 | $207,797 |
| 2025-09-08 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF OPERATING OFFICER | Sell | 13,389 | $477,452 |
Source: SEC Form 4 filings · as of 2026-04-08